Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 34: 2547-2551, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stone, J. A.
Right arrow Articles by Soldin, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stone, J. A.
Right arrow Articles by Soldin, S. J.

Clinical Chemistry, Vol 34, 2547-2551, Copyright © 1988 by American Association for Clinical Chemistry

Improved liquid chromatographic/immunoassay of digoxin in serum

JA Stone and SJ Soldin
Department of Clinical Biochemistry, University of Toronto, Ontario, Canada.

This HPLC/immunoassay procedure measures digoxin in serum with no interference from digoxin metabolites or digoxin-like factors. We used solid-phase (C18 and Diol) extraction, a C18 column with a tetrahydrofuran/water mobile phase, and final quantification by fluorescence polarization immunoassay. Deslanoside and gitoxigenin were used as the internal standard and the retention-time marker, respectively. The average CV for 300-microL samples at digoxin concentrations between 0.9 and 3.9 nmol/L was 9.3%. Minimum column lifetime with daily use was three months. We also compared results, for 49 samples from patients taking digoxin, obtained with the Abbott "TDx FPIA digoxin I" and the present procedure. Discrepancies between the two methods were substantial for 20% of the samples.


The following articles in journals at HighWire Press have cited this article:


Home page
 Drug Metab. Dispos.Home page
S. Song, H. Suzuki, R. Kawai, and Y. Sugiyama
Effect of PSC 833, a P-Glycoprotein Modulator, on the Disposition of Vincristine and Digoxin in Rats
Drug Metab. Dispos., June 1, 1999; 27(6): 689 - 694.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
H. M. A. M. Qazzaz, S. L. Goudy, and R. Valdes Jr.
Deglycosylated Products of Endogenous Digoxin-like Immunoreactive Factor in Mammalian Tissue
J. Biol. Chem., April 12, 1996; 271(15): 8731 - 8737.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.